Search research articles
Contact Us
Filters
Showing results (91-100 of 149) with videos related to
Page
of 15
Sort By:
Annals of the American Thoracic Society
|
April 22, 2022
Multiple-Breath Washout Outcome Measures in Adults with Bronchiectasis
Katherine O'Neill, Gokul R Lakshmipathy, Curtis Neely, et al.
ERJ Open Research
|
January 16, 2024
<i>Mycobacterium avium</i> complex pulmonary disease patients with limited treatment options
Stefano Aliberti, Francesco Blasi, Pierre-Régis Burgel, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 20, 2022
Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study
Amelia Shoemark, Michal Shteinberg, Anthony De Soyza, et al.
The Lancet. Respiratory Medicine
|
November 20, 2016
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study
Melissa J McDonnell, Stefano Aliberti, Pieter C Goeminne, et al.
The New England Journal of Medicine
|
April 23, 2025
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
James D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
Respiratory Medicine
|
December 6, 2024
Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasis
Zina Alfahl, Gisli G Einarsson, J Stuart Elborn, et al.
Trials
|
December 21, 2019
A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial
Judy Martina Bradley, Rohan Anand, Brenda O'Neill, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 5, 2013
BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs
Gerd Döring, Alessandra Bragonzi, Moira Paroni, et al.
The European Respiratory Journal
|
November 6, 2025
Consensus on the management of refractory nontuberculous mycobacterial pulmonary disease
Diana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
Pulmonology
|
February 24, 2026
Management of nontuberculous mycobacterial Pulmonary disease refractory to guideline-based therapy: A systematic review
Diana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 149) with videos related to
Sort By:
Page
of 15
Annals of the American Thoracic Society
|
April 22, 2022
Multiple-Breath Washout Outcome Measures in Adults with Bronchiectasis
Katherine O'Neill, Gokul R Lakshmipathy, Curtis Neely, et al.
ERJ Open Research
|
January 16, 2024
<i>Mycobacterium avium</i> complex pulmonary disease patients with limited treatment options
Stefano Aliberti, Francesco Blasi, Pierre-Régis Burgel, et al.
American Journal of Respiratory and Critical Care Medicine
|
January 20, 2022
Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study
Amelia Shoemark, Michal Shteinberg, Anthony De Soyza, et al.
The Lancet. Respiratory Medicine
|
November 20, 2016
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study
Melissa J McDonnell, Stefano Aliberti, Pieter C Goeminne, et al.
The New England Journal of Medicine
|
April 23, 2025
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
James D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
Respiratory Medicine
|
December 6, 2024
Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasis
Zina Alfahl, Gisli G Einarsson, J Stuart Elborn, et al.
Trials
|
December 21, 2019
A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial
Judy Martina Bradley, Rohan Anand, Brenda O'Neill, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
November 5, 2013
BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs
Gerd Döring, Alessandra Bragonzi, Moira Paroni, et al.
The European Respiratory Journal
|
November 6, 2025
Consensus on the management of refractory nontuberculous mycobacterial pulmonary disease
Diana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
Pulmonology
|
February 24, 2026
Management of nontuberculous mycobacterial Pulmonary disease refractory to guideline-based therapy: A systematic review
Diana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
Page
of 15